JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know Jin Medic

Jin Medical surged 63% after-hours reporting H1 results with revenue down 9.7% to $8.9M, though gross margin improved to 26.9%. R&D spending jumped 33.4%, but the $15M market cap and 84% YoY decline signal structural challenges beyond operational efficiency gains.